Fertility preservation in an oncology patient who presented with positive human chorionic gonadotropin

Objective: To report the case of a woman who presented for fertility preservation before breast cancer treatment who was found to be pregnant with an undesired pregnancy. Design: Case report. Setting: Single infertility practice. Patient: A 28-year-old woman with a new diagnosis of grade 3 invasive...

Full description

Saved in:
Bibliographic Details
Main Authors: Olivia Carpinello, M.D (Author), Alexandra Aserlind, M.D (Author), Frank Chang, M.D (Author), Arthur Sagoskin, M.D (Author), Eric Widra, M.D (Author)
Format: Book
Published: Elsevier, 2020-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8b61d6b7b5a849c2a5d26cd1f0cf6984
042 |a dc 
100 1 0 |a Olivia Carpinello, M.D.  |e author 
700 1 0 |a Alexandra Aserlind, M.D.  |e author 
700 1 0 |a Frank Chang, M.D.  |e author 
700 1 0 |a Arthur Sagoskin, M.D.  |e author 
700 1 0 |a Eric Widra, M.D.  |e author 
245 0 0 |a Fertility preservation in an oncology patient who presented with positive human chorionic gonadotropin 
260 |b Elsevier,   |c 2020-06-01T00:00:00Z. 
500 |a 2666-3341 
500 |a 10.1016/j.xfre.2020.04.007 
520 |a Objective: To report the case of a woman who presented for fertility preservation before breast cancer treatment who was found to be pregnant with an undesired pregnancy. Design: Case report. Setting: Single infertility practice. Patient: A 28-year-old woman with a new diagnosis of grade 3 invasive ductal carcinoma of the breast was planning to undergo oocyte cryopreservation and was found to be pregnant with an undesired pregnancy. She underwent a medical termination at a gestational age of 5 weeks 4 days. Neither the patient nor her oncology team wished to delay treatment more than was necessary. The physician and patient decided to initiate controlled ovarian hyperstimulation (COH) before her human chorionic gonadotropin (hCG) returned to normal. Intervention(s): COH in the setting of a positive quantitative hCG. Main Outcome Measure(s): Number of metaphase II (MII) oocytes cryopreserved; doses of Gonal-F and Menopur; serum E2, follicle-stimulating hormone, luteinizing hormone, hCG levels. Result(s): COH began 7 days after passing the products of conception. Baseline labs demonstrated hCG at 222 mIU/mL, follicle-stimulating hormone at <0.10 mIU/mL, luteinizing hormone at <1.10 mIU/mL, and E2 at 147 pg/mL. She was started on an antagonist protocol with the use of 150 IU Gonal F and 75 IU Menopur. She was triggered on stimulation day 14 with 5,000 U hCG, and her peak E2 was 5,924 pg/mL. She ultimately had 18 oocytes retrieved, 12 of which were MII, one MI, and five germinal vesicle. All were vitrified. Conclusion(s): COH can be achieved in the setting of low positive hCG levels with subsequent successful oocyte maturation. The threshold for hCG trigger to be ineffective in the setting of a positive hCG has yet to be determined. 
546 |a EN 
690 |a Ovarian stimulation 
690 |a fertility preservation 
690 |a pregnancy 
690 |a Diseases of the genitourinary system. Urology 
690 |a RC870-923 
690 |a Gynecology and obstetrics 
690 |a RG1-991 
655 7 |a article  |2 local 
786 0 |n F&S Reports, Vol 1, Iss 1, Pp 51-53 (2020) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2666334120300118 
787 0 |n https://doaj.org/toc/2666-3341 
856 4 1 |u https://doaj.org/article/8b61d6b7b5a849c2a5d26cd1f0cf6984  |z Connect to this object online.